Rebekah L. Rollston, MD, MPH, is a board-certified Family Medicine Physician and Head of Research at Bicycle Health. She earned her Medical Degree from East Tennessee State University Quillen College of Medicine (in the Rural Primary Care Track) and her Master of Public Health (MPH) from The George Washington University Milken Institute School of Public Health. Dr. Rollston completed her residency at Tufts University and Cambridge Health Alliance, a Harvard-affiliated community healthcare system in Greater Boston, with emphases in addiction medicine and sexual & reproductive health. Her professional interests focus on social determinants of health & health equity, addiction medicine, gender-based violence, sexual & reproductive health, rural health, homelessness & supportive housing, and immigrant health. Dr. Rollston has published on these topics in The Lancet, Journal of Health Care for the Poor and Underserved, American Journal of Health Promotion, Journal of Appalachian Health, and Medical Care.
Friday April 28, 2023
Lab Tests and Diagnostics Are Moving to the Home: An Outlook on the OUD Market
- Understanding why remote patient monitoring is a component of so many telehealth service models
- For opioid use disorder (OUD) treatment, monitoring patient urine drug screens (UDS) is an essential component of care to show progress toward goals, maintain patient accountability, prevent diversion, and ensure safety of treatment
- Why embedded safeguards against result falsification are critical to successfully monitor urine drug screens
- Overview of the Bicycle Health home UDS system, as well as results of a clinical research study that evaluated buprenorphine diversion